Samsung Bioepis
FDA Approves Adalimumab Biosimilar
The FDA has approved adalimumab-bwwd (Hadlima, Samsung Bioepis Co.), a biosimilar referencing adalimumab (Humira, ...
JULY 31, 2019
FDA Approves Second Biosimilar of Remicade
Renlexis, a TNF blocker, will be indicated for the treatment of adult and pediatric Crohn’s disease, adult ...
APRIL 24, 2017
Load more